Aurobindo Pharma Limited has informed the Exchange about schedule of Earnings Call to be held on May 22, 2026 at 8:30 AM (IST) on Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2026.
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aurobindo Pharma Limited has scheduled an earnings call for May 22, 2026 at 8:30 AM IST to discuss the company's audited financial results for Q4 and the full year ended March 31, 2026 (Q4FY26). The call will be conducted via Zoom and investors can pre-register through the provided link. The earnings presentation will be made available on the company's website after the results are announced. This filing complies with SEBI Listing Regulation 30(2) requiring disclosure of scheduled investor calls.
This is a routine procedural filing and does not contain any material financial information or guidance. The actual Q4FY26 results will be disclosed separately either before or during the earnings call. This announcement itself is unlikely to have any direct impact on the stock price.